Skip to content

Clinical staging and prognosis cohort study of multiple system atrophy

Clinical staging and prognosis cohort study of multiple system atrophy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300072941
Enrollment
Unknown
Registered
2023-06-28
Start date
2022-07-26
Completion date
Unknown
Last updated
2023-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple system atrophy

Interventions

Case series:none

Sponsors

Xijing Hospital, Air Force Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: ? Patients with MSA who met the diagnostic criteria of probable and likely MSA proposed by Gilman et al. in 2008 and whose diagnosis was confirmed by first-, second-, and third-line physicians; ? Detailed and reliable medical history recall; ? Signed informed consent.

Exclusion criteria

Exclusion criteria: (1) Suffering from other chronic degenerative diseases of the nervous system; (2) Patients with other diseases and serious complications; (3) Those who cause limb mobility disorders or affect the assessment of the condition due to other reasons.

Design outcomes

Primary

MeasureTime frame
Unified Multiple System Atrophy Rating Scale;

Secondary

MeasureTime frame
onset to assisted ambulation;Composite Autonomic Symptom Score-31;International Cooperative Ataxia Rating Scale;Movement Disorder Society Unified Parkinson’s Disease Rating Scale;

Countries

China

Contacts

Public ContactLiu Xuedong

Xijing Hospital, Air Force Medical University

dongxg0752@163.com+86 138 9195 1606

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026